proteins or carbohydrates and are unstable, nonspecific or irreversible.
The postprandial rise in blood glucose is determined by a number of dietary, gastrointestinal, hormonal, and metabolic factors. The aimount of available carbohydrate;' its physical form2 and complexity;3 the presence of dietary protein, faO and dietary fibre" in the meal are all important dietary determinants of the rate of absorption. Abnormalities of the small intestinal mucosa and enzyme deficiencies can slow digestion and thus absorption. The rates of hepatic carbohydrate metabolism, insulin release, and peripheral glucose uptake also regulate blood glucose levels.
Awareness of the importance of close control of blood glucose concentrations in reducing the long term complications of diabetes stimulated research into new ways of stabilising postprandial glycaemia. One approach to this has been by the use of specific inhibitors of the intestinal a-glycosidase hydrolases, because all dietary carbohydrate, with the exception of lactose, is digested by these intestinal enzymes. There are many naturally occurring substances which inhibit these enzymes, but most are complex proteins or carbohydrates and are unstable, nonspecific or irreversible.
The first pure synthetic glycoside hydrolase inhibitor was the pseudotetrasaccharide acarbose ( Fig. la) which was isolated from culture of various genera of Actinomycetes.7 It is a stable compound and a powerful inhibitor of sucrase and maltase activity in vitro8 9 and in vivo in the rat"' and in man. " It was the first inhibitor to be shown to have a reversible effect in the short term' 2 13 and it has no effect on monosaccharide transport mechanisms. ' Figure 2 together with the melan symllptom scores during the 24 hours after dosing for distcnsion (D), flatulence (F) aind loose motions (LM) for the two different inhibitors and placebo taken with sucrose. None of those with loose motions opened their bowels in the first two hours after dosing. The symptoms reported after ol248 were more severe than those after m 1099. Breath hydrogenl concentrations were also higher after oll248, though the differences between individual times or in the areas under the curves were not significantly different.
The effects seen alfter mcaltose were mlarkedly different (Fig. 3) . The postprandial glycaeemic rise was reduced considerably by m1099 but o1248 had no significacnt effect. There was a small rise in breath hydrogen after maltose with m1099 but the symptoms reported were mild. Breath hydrogen levels and symptoms after o1248 and maltose were the same as after the placebo with maltose.
The postprandial glycaemic rise after starch was reduced moderately by ol.248 and miarkedly by m1099 (Fig. 4) . There was a small, late rise in breaith I.
3;
Tm (rrn) Figure 5 compared with the rise after Even the lowest dose of o1248 (5 mg) caused a marked reduction in postprandial glycaemia, a moderate rise in breath hydrogen and some distension and flatulence. The 10 mg and 20 mg doses almost abolished the postprandial glycaemic rise, caused marked evolution of hydrogen and symptoms of similar severity at both dose levels (Fig. 6) . The results at 20 mg were closely similar to those found with the first group of subjects in the substrate specificity study.
The amounts of the 50 g sucrose load which were malabsorbed in the dose response study, as calculated by the ratio of areas under the breath hydrogen curves, are given in Table 2 . Both compounds were well tolerated by all subjects at all In vitro studies with purified at-amylase, however, have shown negligible inhibition of enzyme activity by m1099 or o1248 (Bayer AG, unpublished observations). The explanation of this paradox is not clear but may lie in the fact that both a-dextrinase and glucoamylase are active in hydrolysing malto-oligosaccharides with chain lengths up to nine or more glucose residues. These enzymes may contribute some 'amylase-like' activity to digestion of starch already partly broken down to shorter chain lengths in preparation. HPLC analysis33 of the potato, as eaten by the subjects, however, showed that less than l/o of the carbohydrate present consisted of chains of less than eight glucose residues. The doses used in the substrate specificity studies were based on intestinal perfusion studies in the rat in which these doses were equipotent in inhibiting the disappearance of luminal sucrose. 23 As the inhibitory effect of these doses appears to be almost total after sucrose 5t) g, it is difficult to be sure whether this is a true equivalence in man. The dose response studies suggest that the high dose (20 mg) of o1248 was much more potent in man in inhibiting sucrase activity than was the high dose (50 mg) of m 1099.
The potent sucrase inhibitory effect of both inhibitors has resulted in almost complete malabsorption of the carbohydrate load with its associated symptoms. The differences between the calculated amounts of sucrose malabsorbed in the presence of mO99 50 mg and o1248 20 mg in the two study groups are because of considerable individual variations in breath hydrogen evolution after lactulose and the inherently limited precision of this indirect test. 34 These results must be treated with considerable caution, however, they have some value in giving an indication of the scale of malabsorption produced and the proportions for the two inhibitors are the same for both groups. There was some evidence of malabsorption of maltose with mlt)99 but not with ol-248, though few symptoms were reported with either. There was no breath hydrogen evidence of starch malabsorption with either inhibitor but some symptoms were reported. Intestinal transit of the starch meal was probably much slower than that of the sugar solutions.32 Hydrogen evolution as an indication of malabsorption may thus have occurred later than the four hour collection period, as is hinted by the late rise in breath hydrogen after o1248. 
